Implant Sciences Corporation develops, manufactures, and sells sensors and systems for the security, safety, and defense industries. The company developed proprietary technologies used in explosives and narcotics trace detection (ETD and NTD, respectively) applications and market and sell handheld ETD and desktop ETD and NTD systems that use its proprietary technologies. These systems are used by private companies and government agencies to screen baggage, cargo, other objects and people for the detection of trace amounts of explosives and narcotics. Products The company developed various explosives detection systems designed for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. The systems use its proprietary Quantum Sniffer technologies, including a photon-based, non-radioactive ion source in combination with ion mobility spectrometry (IMS), a classic detection tool sensitive to the speeds with which ions of various substances move through the air to electronically detect minute quantities of explosives vapor and particles. Quantum Sniffer QS-H150 Portable Explosives Detector The Quantum Sniffer QS-H150 Portable Explosives Detector employs a patented vortex collector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time. The QS-H150 can detect vapors and nanogram quantities of explosives particulates for most explosives substances considered to be threats. Such substances include military and commercial explosives, improvised and homemade explosives, propellants and taggants. The QS-H150 has automatic and continuous self-calibration. Quantum Sniffer QS-B220 Desktop Explosives and Narcotics Detector The company’s new QS-B220 Desktop Explosives and Narcotics Detector uses dual IMS with non-radioactive ionization for the detection and identification of a range of military, commercial, and improvised explosives, as well as narcotics. The QS-B220 uses a sample trap, which is wiped on the surface to be interrogated for explosives or narcotics particles. The QS-B220 has automatic and continuous self-calibration. The company offers the QS-B220 at the Force Protection Equipment Demonstration, sponsored by the Department of Defense and Department of Energy. The QS-B220 received regulatory approval from the German Federal Ministry of the Interior for aviation security applications at German airports on March 25, 2014 for use at all non-passenger airport checkpoints for screening of deliveries, food service, and other airport service functions. Products under Development Quantum Sniffer QS-H150E Portable Explosives and Narcotics Detector The company is developing a next-generation handheld detector that would use dual IMS non-radioactive ionization for the detection and identification of a range of military, commercial and improvised explosives, as well as narcotics. The QS-H150E would have automatic and continuous self-calibration, multi-level password-protected data security and would include a data management interface with data export to a network for recordkeeping, providing a link with the central command centers and logistics systems used by major carriers. Miniature Mass Spectrometer The company developed its own proprietary IMS technology. Hyphenated Detectors The company is developing hyphenated systems employing conventional ion mobility, differential mobility and quadrupole mass spectrometry. It has one patent issued in real-time trace detection by IMS and quadrupole mass spectrometry and two hyphenated system patents pending. It has one patent issued and two patents pending in the area of hyphenated detectors. Strategy Key elements of the company’s strategy include focusing on penetrating the U.S. market through transportation security administration qualification and the retention of key advisors; and utilizing its intellectual property to introduce new products and through licensing and joint development agreements. Marketing and Sales The company markets and sells its products through direct sales and marketing staff located in the United States and in China, in addition to a global network of independent and specialized sales representatives and distributors. Intellectual Property The company’s intellectual portfolio contains 23 security-related patents and patents pending: 15 patents have been issued and are active, 6 patents are pending and it licenses 2 patents. 15 issued patents expire in the years 2022 through 2033. Competition Morpho Detection, Inc.; Smiths Detection, Inc.; and NucTech Company Limited are the company’s primary competitors in trace explosives and narcotics detection markets worldwide. Research and Development The company spent approximately $4,787,000 on internally funded research and development in the fiscal year ended June 30, 2014. History Implant Sciences Corporation was founded in 1984. The company was incorporated in 1984.
implant sciences corp (IMSC:OTC US)
500 Research Drive
Wilmington, MA 01887
|Bruker Corp||$18.73 USD||+0.21|
|CR Bard Inc||$196.49 USD||+7.05|
|Safran SA||€67.83 EUR||+0.57|
|Thermo Fisher Scientific Inc||$127.91 USD||+2.65|
|View Industry Companies|
|Price/Cash Flow||--||Not Meaningful|
Sponsored Financial Commentaries
To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.